The latest news:

• Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma         This is an interesting trial design - hey tested every combination of temodar and 3 add on drugs... there probably wasn't enough patients to be sure but early result look like adding isotretinoin  (Accutane) actually did worse than temodar alone, and none of the combinations did much better than temodar alone. The best was all 3 drugs plus temodar, but not by much over temodar alone.  
  



• New Ben Williams article posted on Virtualtrials.com: Long Term Survivors of GBMs        Ben is an old friend of mine. He is  a 19 year survivor of a gbm, and has done extensive writing on the subject.  The link will bring you to his page where you can see more of his articles as well.  This article on long term survivors explores how rare it is to actually survive so long. May be depressing but it shows the need for more research and to be more aggressive in finding treatments.
  

BrainTumor Co-Payment Assistance Program Status:

• OPEN to new applicants